Naloxotel is a software application to assign percent risk of opioid-induced respiratory depression based on a validated multivariate linear regression model coupled with drug interactions.  This app will enable pharmacists and medical providers to generate a very comprehensive assessment for validating the initiation of and third party payment for in-home naloxone access.